Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.65B |
| 2 |
Microsoft
MSFT
|
+$565M |
| 3 |
Amazon
AMZN
|
+$452M |
| 4 |
NXP Semiconductors
NXPI
|
+$315M |
| 5 |
International Flavors & Fragrances
IFF
|
+$310M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$220M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$186M |
| 3 |
Booking.com
BKNG
|
+$117M |
| 4 |
EV
Eaton Vance Corp.
EV
|
+$104M |
| 5 |
Moody's
MCO
|
+$62.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.27% |
| 2 | Financials | 13.76% |
| 3 | Healthcare | 13.2% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
2151
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $13.3M | ﹤0.01% |
458,313
+112,796
| +33% | +$3.16M |
|
2152
RB Global
RBA
$20.9B
| $13.3M | ﹤0.01% |
227,969
+21,698
| +11% | +$1.27M |
|
|
ABTX
2153
DELISTED
Allegiance Bancshares
ABTX
| $13.3M | ﹤0.01% |
328,172
+22,329
| +7% | +$852K |
|
2154
Organogenesis Holdings
ORGO
$301M
| $13.3M | ﹤0.01% |
730,112
+14,660
| +2% | +$199K |
|
2155
Donnelley Financial Solutions
DFIN
$1.2B
| $13.3M | ﹤0.01% |
476,790
+37,066
| +8% | +$858K |
|
2156
Rhythm Pharmaceuticals
RYTM
$7.05B
| $13.3M | ﹤0.01% |
623,562
+135,115
| +28% | +$3.92M |
|
|
GTHX
2157
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $13.3M | ﹤0.01% |
551,183
+67,343
| +14% | +$1.57M |
|
2158
Caleres
CAL
$470M
| $13.2M | ﹤0.01% |
607,790
+62,055
| +11% | +$1.06M |
|
2159
Weis Markets
WMK
$1.94B
| $13.2M | ﹤0.01% |
234,046
+21,398
| +10% | +$1.15M |
|
2160
Cameco
CCJ
$39.1B
| $13.2M | ﹤0.01% |
803,331
+65,326
| +9% | +$1M |
|
2161
Varex Imaging
VREX
$502M
| $13.2M | ﹤0.01% |
644,464
+60,071
| +10% | +$1.29M |
|
2162
Replimune Group
REPL
$1B
| $13.2M | ﹤0.01% |
431,929
+51,037
| +13% | +$1.91M |
|
|
CNST
2163
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $13.1M | ﹤0.01% |
561,845
+63,637
| +13% | +$1.93M |
|
2164
OptimizeRx
OPRX
$123M
| $13.1M | ﹤0.01% |
269,492
+38,832
| +17% | +$1.87M |
|
2165
Horizon Bancorp
HBNC
$1.06B
| $13.1M | ﹤0.01% |
705,912
+59,868
| +9% | +$1.06M |
|
2166
Sanofi
SNY
$103B
| $13.1M | ﹤0.01% |
264,775
+7,681
| +3% | +$369K |
|
2167
Kelly Services Class A
KELYA
$520M
| $13.1M | ﹤0.01% |
586,350
+59,722
| +11% | +$1.27M |
|
2168
Great Southern Bancorp
GSBC
$886M
| $13.1M | ﹤0.01% |
230,386
+13,173
| +6% | +$704K |
|
|
HONE
2169
DELISTED
HarborOne Bancorp
HONE
| $13M | ﹤0.01% |
967,568
+58,308
| +6% | +$709K |
|
2170
Ribbon Communications
RBBN
$379M
| $13M | ﹤0.01% |
1,582,892
+146,231
| +10% | +$1.21M |
|
|
FBMS
2171
DELISTED
The First Bancshares, Inc.
FBMS
| $13M | ﹤0.01% |
353,835
+28,043
| +9% | +$941K |
|
|
SRG
2172
Seritage Growth Properties
SRG
$137M
| $12.9M | ﹤0.01% |
704,424
+42,564
| +6% | +$789K |
|
|
MGP
2173
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $12.9M | ﹤0.01% |
396,179
+52,123
| +15% | +$1.69M |
|
2174
Helix Energy Solutions
HLX
$1.36B
| $12.9M | ﹤0.01% |
2,557,108
+247,032
| +11% | +$1.23M |
|
2175
Sutro Biopharma
STRO
$416M
| $12.9M | ﹤0.01% |
56,665
+14,813
| +35% | +$3.51M |
|
Similar funds
Geode Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, Geode Capital Management held 4,537 positions worth $654B, up 9.7% from $596B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geode Capital Management deployed $22.8B of net new capital in Q1 2021, opening 282 new positions and adding to 3,569 existing holdings. Its largest new stake was Texas Pacific Land: 546,273 shares worth $96.5M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was DuPont de Nemours, an estimated $220M trimmed.
- Geode Capital Management's largest Q1 2021 buy was Texas Pacific Land: 546,273 shares worth $96.5M.
- Geode Capital Management added most to Sherwin-Williams in Q1 2021, an estimated $1.65B increase.
- Geode Capital Management's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $220M.
- Geode Capital Management fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $186M.
- Geode Capital Management's ten largest holdings make up 21% of its $654B portfolio in Q1 2021.
- Geode Capital Management opened 282 new positions and closed 88 in Q1 2021.
- Geode Capital Management's portfolio value rose 9.7% quarter-over-quarter to $654B.
Based on Geode Capital Management's 13F filing for Q1 2021, filed 12 May 2021.